| 发明名称 |
Fluorescent creatinine assay |
| 摘要 |
A method of detecting creatinine in body fluids using an indicator which produces a fluorescent response when oxidized in the presence of a copper<II>/creatinine complex. A preferred indicator is 4-(1-methylhydrazino)-7-nitro benzooxadiazole (MNBDH). |
| 申请公布号 |
AU2003297862(A8) |
申请公布日期 |
2004.07.29 |
| 申请号 |
AU20030297862 |
申请日期 |
2003.12.11 |
| 申请人 |
BAYER HEALTHCARE LLC |
发明人 |
ROBERT P. HATCH;JAMES P. ALBARELLA |
| 分类号 |
C07C;C12Q1/28;G01N33/00;G01N33/58;G01N33/70;(IPC1-7):G01N33/00 |
主分类号 |
C07C |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
